Design of novel bone-targeting chemical groups and their exploitation in the discovery of anti-resorptive Src tyrosine kinase inhibitors.

被引:0
|
作者
Dalgarno, D
Pradeepan, S
Yuan, R
Bogus, J
Wardwell, S
Xing, L
Ram, M
Liou, S
Keats, J
Narula, S
Metcalf, C
Wang, Y
Keenan, T
Sundaramoorthi, R
Shakespeare, W
Sebesta, C
Bohacek, R
van Schravendijk, MR
Boyce, B
Iuliucci, J
Weigele, M
Sawyer, T
机构
[1] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA
[2] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[3] Primedica, Worcester, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S507 / S507
页数:1
相关论文
共 39 条
  • [21] Design, Synthesis and Pharmacokinetic Evaluation of a Novel Series of Triazole-Based Src Kinase Inhibitors with Anti-proliferative Activity
    Chen, Shaojun
    Guo, Chuansheng
    Shi, Shiting
    Shi, Yanyan
    Fang, Du
    Fan, Houxing
    LETTERS IN DRUG DESIGN & DISCOVERY, 2011, 8 (01) : 9 - 13
  • [22] Bone-targeted pyrido[2,3-d]pyrimidin-7-ones:: Potent inhibitors of Src tyrosine kinase as novel antiresorptive agents
    Vu, CB
    Luke, GP
    Kawahata, N
    Shakespeare, WC
    Wang, YH
    Sundaramoorthi, R
    Metcalf, CA
    Keenan, TP
    Pradeepan, S
    Corpuz, E
    Merry, T
    Bohacek, RS
    Dalgarno, DC
    Narula, SS
    van Schravendijk, MR
    Ram, MK
    Adams, S
    Liou, S
    Keats, JA
    Violette, SM
    Guan, W
    Weigele, M
    Sawyer, TK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (18) : 3071 - 3074
  • [23] Novel Src tyrosine kinase inhibitors prevent ovariectomy-induced bone loss in a Swiss-Webster mouse model of post-menopausal osteoporosis.
    von Stechow, D
    Alexander, JM
    Fish, S
    Chorev, M
    Mueller, R
    Rosenblatt, M
    Illiucci, J
    Wang, Y
    Metcalf, C
    Keenan, T
    Sundaramoorthi, R
    Shakespeare, W
    van Schravendijk, MR
    Dalgamo, D
    Sawyer, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S223 - S223
  • [24] In Silico Screening for Novel Tyrosine Kinase Inhibitors with Oxindole Scaffold as Anti-Cancer Agents: Design, QSAR Analysis, Molecular Docking and ADMET Studies
    Zangeneh, Jalalaldin
    Shirvani, Pouria
    Etebari, Mahmoud
    Saghaie, Lotfollah
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2022, 21 (05): : 583 - 598
  • [25] Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer
    Nafie, Mohamed S.
    Boraei, Ahmed T. A.
    BIOORGANIC CHEMISTRY, 2022, 122
  • [26] Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2
    El-Naggar, Abeer M.
    Hassan, A. M. A.
    Elkaeed, Eslam B.
    Alesawy, Mohamed S.
    Al-Karmalawy, Ahmed A.
    BIOORGANIC CHEMISTRY, 2022, 123
  • [27] The design and discovery of water soluble 4-substituted-2, 6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents
    Zhang, Xin
    Raghavan, Sudhir
    Ihnat, Michael
    Thorpe, Jessica E.
    Disch, Bryan C.
    Bastian, Anja
    Bailey-Downs, Lora C.
    Dybdal-Hargreaves, Nicholas F.
    Rohena, Cristina C.
    Hamel, Ernest
    Mooberry, Susan L.
    Gangjee, Aleem
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (14) : 3753 - 3772
  • [28] Discovery and Rational Design of Pteridin-7(8H)-one-Based Inhibitors Targeting FMS-like Tyrosine Kinase 3 (FLT3) and Its Mutants
    Sun, Deheng
    Yang, Yu
    Lyu, Jiankun
    Zhou, Wei
    Song, Wenlin
    Zhao, Zhenjiang
    Chen, Zhuo
    Xu, Yufang
    Li, Honglin
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (13) : 6187 - 6200
  • [29] Novel Design of RNA Aptamers as Cancer Inhibitors and Diagnosis Targeting the Tyrosine Kinase Domain of the NT-3 Growth Factor Receptor Using a Computational Sequence-Based Approach
    Muhammad, Ashraf M.
    Zari, Ali
    Alsubhi, Nouf H.
    Al-Zahrani, Maryam H.
    Alghamdi, Rana Abdullah
    Labib, Mai M.
    MOLECULES, 2022, 27 (14):
  • [30] Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase
    Srivastava, Jitendra Kumar
    Pillai, Girinath G.
    Bhat, Hans Raj
    Verma, Amita
    Singh, Udaya Pratap
    SCIENTIFIC REPORTS, 2017, 7